Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages

Current Opinion in Lipidology

Volumn 17, Issue 3, 2006, Pages 247-257

  Jessup, Wendy ^a,b   Gelissen, Ingrid C ^a,b   Gaus, Katharina ^a,b   Kritharides, Leonard ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Cholesterol efflux; Macrophage; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BREAST CANCER RESISTANCE PROTEIN; MEMBRANE LIPID; SCAVENGER RECEPTOR BI;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; HUMAN; LIPID RAFT; MACROPHAGE; MEMBRANE TRANSPORT; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; CHOLESTEROL; HUMANS; MACROPHAGES; SCAVENGER RECEPTORS, CLASS B;

EID: 33646867218     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000226116.35555.eb     Document Type: Review

References (118)

1. Yancey PG, Bortnick AE, Kellner-Weibel G, et al. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003; 23:712-719.
2. Rigotti A, Miettinen HE, Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 2003; 24:357-387.
3. Oram JF, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005; 85:1343-1372.
4. Boadu E, Francis GA. The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways. J Mol Med 2005; 17 November [Epub ahead of print].
5. Schmitz G, Langmann T, Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res 2001; 42:1513-1520.
6. Van Eck M, Pennings M, Hoekstra M, et al. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 2005; 16:307-315.
7. Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov 2005; 4:193-205.
8. Connelly MA, Williams DL. Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opin Lipidol 2004; 15:287-295.
9. Liscum L, Munn NJ. Intracellular cholesterol transport. Biochim Biophys Acta 1999; 1438:19-37.
10. Simons K, Ikonen E. How cells handle cholesterol. Science 2000; 290:1721-1726.
11. Holthuis JC, Levine TP. Lipid traffic: floppy drives and a superhighway. Nat Rev Mol Cell Biol 2005; 6:209-220. An excellent introduction to current concepts of intracellular lipid transport.
12. Soccio RE, Breslow JL. Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol 2004; 24:1150-1160.
13. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1:31-39.
14. Simons K, Vaz WL. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 2004; 33:269-295.
15. Gaus K, Kritharides L, Schmitz G, et al. Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. FASEB J 2004; 18:574-576.
16. Gaus K, Rodriguez M, Ruberu KR, et al. Domain-specific lipid distribution in macrophage plasma membranes. J Lipid Res 2005; 46:1526-1538. This study provides details of human macrophage plasma membrane lipid composition and provides a critical assessment of various methods used to prepare lipid-raft fractions from the plasma membrane.
17. Foster LJ, De Hoog CL, Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 2003; 100:5813-5818.
18. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 2003; 32:257-283.
19. Shogomori H, Brown DA. Use of detergents to study membrane rafts: the good, the bad, and the ugly. Biol Chem 2003; 384:1259-1263.
20. Fielding CJ, Fielding PE. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta 2003; 1610:219-228.
21. Ikonen E, Heino S, Lusa S. Caveolins and membrane cholesterol. Biochem Soc Trans 2004; 32:121-123.
22. Gaus K, Chklovskaia E, Fazekas de St Groth B, et al. Condensation of the plasma membrane at the site of T lymphocyte activation. J Cell Biol 2005; 171:121-131. Demonstration of how large raft-like domains form and can be tracked microscopically in real time.
23. Gaus K, Gratton E, Kable EP, et al. Visualizing lipid structure and raft domains in living cells with two-photon microscopy. Proc Natl Acad Sci U S A 2003; 100:15554-15559.
24. Kusumi A, Suzuki K. Toward understanding the dynamics of membrane-raft-based molecular interactions. Biochim Biophys Acta 2005; 1746:234-251.
25. Lund-Katz S, Laboda HM, McLean LR, Phillips MC. Influence of molecular packing and phospholipid type on rates of cholesterol exchange. Biochemistry 1988; 27:3416-3423.
26. van Eck M, Bos IS, Kaminski WE, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 2002; 99:6298-6303.
27. Aiello RJ, Brees D, Francone OL. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler Thromb Vasc Biol 2003; 23:972-980.
28. Kielar D, Dietmaier W, Langmann T, et al. Rapid quantification of human ABCA1 mRNA in various cell types and tissues by real-time reverse transcription-PCR. Clin Chem 2001; 47:2089-2097.
29. Schmitz G, Langmann T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta 2005; 1735:1-19.
30. Kiss RS, Maric J, Marcel YL. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux. J Lipid Res 2005; 46:1877-1887.
31. Wang N, Silver DL, Costet P, Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000; 275:33053-33058.
32. Vaughan AM, Oram JF. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J Lipid Res 2003; 44:1373-1380.
33. Mendez AJ, Lin G, Wade DP, et al. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 2001; 276:3518-3566.
34. Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 2001; 276:23742-23747.
35. Fielding PE, Nagao K, Hakamata H, et al. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. Biochemistry 2000; 39:14113-14120.
36. Li Q, Tsujita M, Yokoyama S. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 1997; 36:12045-12052.
37. Arakawa R, Abe-Dohmae S, Asai M, et al. Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells. J Lipid Res 2000; 41:1952-1962.
38. Zheng H, Kiss RS, Franklin V, et al. ApoA-I lipidation in primary mouse hepatocytes: separate controls for phospholipid and cholesterol transfers. J Biol Chem 2005; 280:21612-21621.
39. Smith JD, Le Goff W, Settle M, et al. ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J Lipid Res 2004; 45:635-644.
40. Wang N, Lan D, Gerbod-Giannone M, et al. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem 2003; 278:42906-42912.
41. Gillotte KL, Davidson WS, Lund-Katz S, et al. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization. J Lipid Res 1998; 39:1918-1928.
42. Nieland TJ, Chroni A, Fitzgerald ML, et al. Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res 2004; 45:1256-1265.
43. Fitzgerald ML, Morris AL, Rhee JS, et al. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 2002; 277:33178-33187.
44. Chen W, Wang N, Tall AR. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J Biol Chem 2005; 280:29277-29281. Mutation in the cytoplasmic PEST domain of ABCA1 alters ABCA1 subcellular distribution and ability to promote export of intracellular versus surface cholesterol.
45. Gaus K, Gooding JJ, Dean RT, et al. A kinetic model to evaluate cholesterol efflux from THP-1 macrophages to apolipoprotein A-1. Biochemistry 2001; 40:9363-9373.
46. Gaus K, Dean RT, Kritharides L, Jessup W. Inhibition of cholesterol efflux by 7-ketocholesterol: comparison between cells, plasma membrane vesicles, and liposomes as cholesterol donors. Biochemistry 2001; 40:13002-13014.
47. Gelissen IC, Brown AJ, Mander EL, et al. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem 1996; 271:17852-17860.
48. Ito J, Nagayasu Y, Yokoyama S. Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux. J Lipid Res 2000; 41:894-904.
49. Sun Y, Hao M, Luo Y, et al. Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure. J Biol Chem 2003; 278:5813-5820.
50. Drobnik W, Borsukova H, Bottcher A, et al. Apo Al/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 2002; 3:268-278.
51. Hinrichs JW, Klappe K, van Riezen M, Kok JW. Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains. J Lipid Res 2005; 46:2367-2376.
52. Klucken J, Buchler C, Orso E, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci U S A 2000; 97:817-822.
53. Kage K, Tsukahara S, Sugiyama T, et al. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer 2002; 97:626-630.
54. Graf GA, Li WP, Gerard RD, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002; 110:659-669.
55. Wang N, Lan D, Chen W, et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004; 101:9774-9779.
56. Nakamura K, Kennedy MA, Baldan A, et al. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J Biol Chem 2004; 279:45980-45989.
57. Vaughan AM, Oram JF. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J Biol Chem 2005; 280:30150-30157. The first paper to describe many properties of ABCG1 in a stably overexpressing cell line.
58. Gelissen IC, Harris M, Rye KA, et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 2006; 26:534-540. This paper shows that apoAI which has been lipidated by exposure to ABCA1 is a substrate for ABCG1.
59. Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005; 1:121-131. This is the first description of the phenotype of ABCG1-null and overexpressing mice and provides important evidence for a role for this transporter in macrophage lipid accumulation in vivo.
60. Neufeld EB, O'Brien KG, S.J. D et al. ABCG1-modified plasma membrane lipid domains mediate cellular cholesterol efflux to HDL. Circulation 2005; 112 (Suppl II):II-104.
61. Karten B, Campenot RB, Vance DE, Vance JE. Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. J Biol Chem 2006; 281:4049-4057.
62. Cserepes J, Szentpetery Z, Seres L, et al. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem Biophys Res Commun 2004; 320:860-867.
63. Lorkowski S, Kratz M, Wenner C, et al. Expression of the ATP-binding cassette transporter gene ABCG1 (ABC8) in Tangier disease. Biochem Biophys Res Commun 2001; 283:821-830.
64. Hoekstra M, Kruijt JK, Van Eck M, Van Berkel TJ. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J Biol Chem 2003; 278:25448-25453.
65. Venkateswaran A, Repa JJ, Lobaccaro JM, et al. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages: a transcriptional role for specific oxysterols. J Biol Chem 2000; 275:14700-14707.
66. Kennedy MA, Venkateswaran A, Tarr PT, et al. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem 2001; 276:39438-39447.
67. Sabol SL, Brewer HB Jr, Santamarina-Fojo S. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 2005; 46:2151-2167.
68. Wong J, Quinn CM, Brown AJ. Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux. Arterioscler Thromb Vasc Biol 2004; 24:2365-2371.
69. Rowe AH, Argmann CA, Edwards JY, et al. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene : lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circ Res.932003717725.
70. Li AC, Binder CJ, Gutierrez A, et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 2004; 114:1564-1576.
71. Khovidhunkit W, Moser AH, Shigenaga JK, et al. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res 2003; 44:1728-1736.
72. Argmann CA, Van Den Diepstraten CH, Sawyez CG, et al. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol 2001; 21:2011-2018.
73. Rubic T, Lorenz RL. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res 2006; 69:527-535.
74. Langmann T, Klucken J, Reil M, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 1999; 257:29-33.
75. Yu L, Cao G, Repa J, Stangl H. Sterol regulation of scavenger receptor class B type I in macrophages. J Lipid Res 2004; 45:889-899.
76. Han J, Nicholson AC, Zhou X, et al. Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. J Biol Chem 2001; 276:16567-16572.
77. Hirano K, Yamashita S, Nakagawa Y, et al. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res 1999; 85:108-116.
78. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000; 275:28240-28245.
79. Chinetti G, Gbaguidi FG, Griglio S, et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 2000; 101:2411-2417.
80. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000; 275:34508-34511.
81. Ji Y, Jian B, Wang N, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272:20982-20985.
82. Remaley AT, Stonik JA, Demosky SJ, et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 2001; 280:818-823.
83. Oram JF, Vaughan AM, Stocker R. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem 2001; 276:39898-39902.
84. de la Llera-Moya M, Rothblat GH, Connelly MA, et al. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res 1999; 40:575-580.
85. Favari E, Lee M, Calabresi L, et al. Depletion of pre-{beta}-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 2004; 279:9930-9936.
86. Smith JD, Miyata M, Ginsberg M, et al. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem 1996; 271:30647-30655.
87. Williams DL, Wong JS, Hamilton RL SR-BI is required for microvillar channel formation and the localization of HDL particles to the surface of adrenocortical cells in vivo. J Lipid Res 2002; 43:544-549.
88. Reaven E, Leers-Sucheta S, Nomoto A, Azhar S. Expression of scavenger receptor class B type 1 (SR-BI) promotes microvillar channel formation and selective cholesteryl ester transport in a heterologous reconstituted system. Proc Natl Acad Sci U S A 2001; 98:1613-1618.
89. Zhang Y, Da Silva JR, Reilly M, et al. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 2005; 115:2870-2874. This study demonstrated that hepatic-specific expression of SR-BI promoted biliary excretion of peripheral cholesterol, indicating that SR-BI expressed in the liver may influence reverse cholesterol transport in distal tissues.
90. Singaraja RR, Fievet C, Castro G, et al. Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 2002; 110:35-42.
91. Joyce CW, Amar MJA, Lambert G, et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A 2002; 99:407-412.
92. Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000; 275:20368-20373.
93. Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20:721-727.
94. Bates SR, Tao J-Q, Collins HL, et al. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289:L980-L989.
95. Yesilaltay A, Morales MG, Amigo L, et al. Effects of hepatic expression of the HDL-receptor SR-BI on lipoprotein metabolism and female fertility. Endocrinology 2006; 12 January [Epub ahead of print]:
96. Zhang Y, Da Silva JR, Reilly M, et al. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 2005; 115:2870-2874.
97. Zhang W, Yancey PG, Su YR, et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 2003; 108:2258-2263.
98. Covey SD, Krieger M, Wang W, et al. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler Thromb Vasc Biol 2003; 23:1589-1594.
99. Huang ZH, Gu D, Lange Y, Mazzone T. Expression of scavenger receptor BI facilitates sterol movement between the plasma membrane and the endoplasmic reticulum in macrophages. Biochemistry 2003; 42:3949-3955.
100. Nakagawa-Toyama Y, Hirano K, Tsujii K, et al. Human scavenger receptor class B type I is expressed with cell-specific fashion in both initial and terminal site of reverse cholesterol transport. Atherosclerosis 2005; 183:75-83.
101. Jian B, de la Llera-Moya M, Ji Y, et al. Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem 1998; 273:5599-5606.
102. Treguier M, Doucet C, Moreau M, et al. Transcription factor sterol regulatory element binding protein 2 regulates scavenger receptor Cla-1 gene expression. Arterioscler Thromb Vasc Biol 2004; 24:2358-2364.
103. Svensson PA, Englund MC, Snackestrand MS, et al. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques. BMC Cardiovasc Disord 2005; 5:25.
104. Babitt J, Trigatti B, Rigotti A, et al. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997; 272:13242-13249.
105. Matveev S, van der Westhuyzen DR, Smart EJ. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J Lipid Res 1999; 40:1647-1654.
106. Graf GA, Connell PM, van der Westhuyzen DR, Smart EJ. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. J Biol Chem 1999; 274:12043-12048.
107. Wang L, Connelly MA, Ostermeyer AG, et al. Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines. J Lipid Res 2003; 44:807-815.
108. Matveev S, Uittenbogaard A, van Der Westhuyzen D, Smart EJ. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur J Biochem 2001; 268:5609-5616.
109. Briand O, Lestavel S, Pilon A, et al. SR-BI does not require raft/caveola localisation for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R. Biochim Biophys Acta 2003; 1631:42-50.
110. Peng Y, Akmentin W, Connelly MA, et al. Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. Mol Biol Cell 2004; 15:384-396.
111. Kellner-Weibel G, de La Llera-Moya M, Connelly MA, et al. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry 2000; 39:221-229.
112. Connelly MA, De La Llera-Moya M, Peng Y, et al. Separation of lipid transport functions by mutations in the extracellular domain of scavenger receptor class B, type I. J Biol Chem 2003; 278:25773-25782.
113. Curtiss LK, Valenta DT, Hime NJ, Rye K-A. What is so special about apolipoprotein Al in reverse cholesterol transport? Arterioscler Thromb Vasc Biol 2006; 26:12-19.
114. Chen W, Silver DL, Smith JD, Tall AR. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages. J Biol Chem 2000; 275:30794-30800.
115. Yancey PG, Kawashiri M-A, Moore R, et al. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux. J Lipid Res 2004; 45:337-346.
116. Asztalos BF, de la Llera-Moya M, Dallal GE, et al. Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res 2005; 46:2246-2253.
117. O'Connell BJ, Denis M, Genest J. Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation 2004; 110:2881-2888.
118. Duong M, Collins HL, Jin W, et al. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 2006; 26:541-547. This interesting study uses a combined approach in transfection and induction of transporters together with inhibitors to dissect the relative contributions of ABCA1 and SR-BI to cholesterol efflux to whole serum, concluding that a significant proportion of efflux is independent of either.